The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.

Cytotoxic T lymphocytes (CTL) directed against human immunodeficiency virus (HIV)-1 are detectable in the majority of infected individuals, and their early appearance as the initial viremia is suppressed is thought to represent a potent antiviral response. Variation which arises in CTL epitopes can...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Klenerman, P, Meier, U, Phillips, R, Mcmichael, A
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: 1995
_version_ 1826292453653610496
author Klenerman, P
Meier, U
Phillips, R
Mcmichael, A
author_facet Klenerman, P
Meier, U
Phillips, R
Mcmichael, A
author_sort Klenerman, P
collection OXFORD
description Cytotoxic T lymphocytes (CTL) directed against human immunodeficiency virus (HIV)-1 are detectable in the majority of infected individuals, and their early appearance as the initial viremia is suppressed is thought to represent a potent antiviral response. Variation which arises in CTL epitopes can affect recognition by CTL, and we have observed previously that variant epitopes in HIV-1 gag which arise in HIV-1-seropositive donors may act as T cell receptor (TCR) antagonists of their own CTL (Klenerman et al., Nature 1994, 369: 403). The most important question arising from these observations is the extent of these immune escape mechanisms in vivo. Here we show that fresh, uncultured lymphocytes taken directly from HIV-1-infected patients are susceptible to TCR antagonism by variants present within their own virus. In contrast to HLA Class II-restricted T cell responses, where anergy may be induced, we find that in vitro, natural variants may stimulate and sustain growth of CTL. These CTL lines retain lytic specificity exclusively for the original peptide. If this represents events in vivo, natural HIV altered peptide ligands (APL) have the capacity to inhibit the range of CTL directed against an epitope, not simply those clones selected in vitro. Partial activation of CTL by APL could also act to drive an ineffectual CTL response incapable of lysing infected cells bearing these natural antigenic variants. Distortion of lymphocyte populations and function by APL might represent a further mechanism of immune evasion by HIV.
first_indexed 2024-03-07T03:14:56Z
format Journal article
id oxford-uuid:b57b7f5a-58ab-4883-a9f6-8c60a4be8967
institution University of Oxford
language English
last_indexed 2024-03-07T03:14:56Z
publishDate 1995
record_format dspace
spelling oxford-uuid:b57b7f5a-58ab-4883-a9f6-8c60a4be89672022-03-27T04:33:40ZThe effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b57b7f5a-58ab-4883-a9f6-8c60a4be8967EnglishSymplectic Elements at Oxford1995Klenerman, PMeier, UPhillips, RMcmichael, ACytotoxic T lymphocytes (CTL) directed against human immunodeficiency virus (HIV)-1 are detectable in the majority of infected individuals, and their early appearance as the initial viremia is suppressed is thought to represent a potent antiviral response. Variation which arises in CTL epitopes can affect recognition by CTL, and we have observed previously that variant epitopes in HIV-1 gag which arise in HIV-1-seropositive donors may act as T cell receptor (TCR) antagonists of their own CTL (Klenerman et al., Nature 1994, 369: 403). The most important question arising from these observations is the extent of these immune escape mechanisms in vivo. Here we show that fresh, uncultured lymphocytes taken directly from HIV-1-infected patients are susceptible to TCR antagonism by variants present within their own virus. In contrast to HLA Class II-restricted T cell responses, where anergy may be induced, we find that in vitro, natural variants may stimulate and sustain growth of CTL. These CTL lines retain lytic specificity exclusively for the original peptide. If this represents events in vivo, natural HIV altered peptide ligands (APL) have the capacity to inhibit the range of CTL directed against an epitope, not simply those clones selected in vitro. Partial activation of CTL by APL could also act to drive an ineffectual CTL response incapable of lysing infected cells bearing these natural antigenic variants. Distortion of lymphocyte populations and function by APL might represent a further mechanism of immune evasion by HIV.
spellingShingle Klenerman, P
Meier, U
Phillips, R
Mcmichael, A
The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title_full The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title_fullStr The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title_full_unstemmed The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title_short The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
title_sort effects of natural altered peptide ligands on the whole blood cytotoxic t lymphocyte response to human immunodeficiency virus
work_keys_str_mv AT klenermanp theeffectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT meieru theeffectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT phillipsr theeffectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT mcmichaela theeffectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT klenermanp effectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT meieru effectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT phillipsr effectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus
AT mcmichaela effectsofnaturalalteredpeptideligandsonthewholebloodcytotoxictlymphocyteresponsetohumanimmunodeficiencyvirus